Clinical trial · Interventional
The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study
A Pilot Study: The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients
NCT01043068CI-TRIAL-00006806completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study was to prospectively evaluate the effect of cancer pain management protocol on hospitalized cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancers, Pain | Malignant Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cancer pain management | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Pain control
- description
- Interventions based on published pain guideline. The interventions consisted of the following: (1) nursing pain assessment of current pain, worst pain, pain relief, and acceptability of pain; (2) feedback to guide analgesic prescribing by physician.
- interventionNames
- Drug: Cancer pain management
Primary outcomes (1)
- measure
- Reduction in pain scores
- timeFrame
- Jan 2010 - October 2010
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Hospitalized patient with the somatic and/or visceral pain having an untreated intensity greater than 3 on a 10 cm visual analog scale (VAS; 0 = no pain, 10 = unbearable pain)over the week prior to enrollment * A minimum age of 18 years Exclusion Criteria: * Opioid intolerance * No longer treatment for their underlying disease. * Intracerebral primary or metastatic lesion * Impaired sensory or cognitive function * Pregnant or lactating woman * Women of child bearing potential not using a contraceptive method * Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential * Any patients judged by the investigator to be unfit to participate in the study
References
Publications (0)
Data not yet available
No reference posted for this study.